Out-licensing

Our client is looking for partners to further develop and commercialize stem cells, sourced from adipose tissue for the treatment of regenerative medicine and ageing.

The stem cells on offer from our Swiss client company offer enormous potential for therapeutic indications such as osteoarthritis, diabetes, ophthalmology and stroke. Our clients are looking for a partner who has the experience and know-how to advance the stem cells through to clinical trials and beyond.

Any interested companies should not only have the research and development capabilities but also the financial backing to transform the stem cells into breakthrough medications.

 

Early Stage

The client will consider commercial agreements, joint ventures or a partial exit through M&A. Companies of interest to the company are leading pharmaceutical companies, cosmetic companies who could develop skin care treatments and research companies who could use the stem cells for research and development purposes.